Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Myelogenous Leukemia in Chronic Phase”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00005622
What this trial is testing

Donor Bone Marrow Transplant in Treating Patients With Leukemia, Lymphoma, or Nonmalignant Hematologic Disorders

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMultiple Myeloma and Malignant Plasma Cell Neoplasms+2 more
H. Lee Moffitt Cancer Center and Research Institute 72
Post-approval studies (Phase 4)Looking for participantsNCT04877522
What this trial is testing

Asciminib Roll-over Study

Who this might be right for
Chronic Myelogenous LeukemiaLeukemia, Myelogenous, Chronic, BCR-ABL Positive
Novartis Pharmaceuticals 347
Testing effectiveness (Phase 2)Study completedNCT00002574
What this trial is testing

Homoharringtonine and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
National Cancer Institute (NCI) 87
Testing effectiveness (Phase 2)Study completedNCT00038597
What this trial is testing

Phase II Study of SCH66336, A Farnesyltransferase Inhibitor in Chronic Myelogenous Leukemia (CML)

Who this might be right for
Myelogenous Leukemia, Chronic
M.D. Anderson Cancer Center 13
Early research (Phase 1)Study completedNCT00024180
What this trial is testing

FR901228 in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphoma
Ohio State University Comprehensive Cancer Center
Large-scale testing (Phase 3)Study completedNCT00333840
What this trial is testing

Safety and Efficacy of Imatinib Versus Interferon-α Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia

Who this might be right for
Chronic Myelogenous Leukemia
Novartis Pharmaceuticals 1,106
Large-scale testing (Phase 3)Study completedNCT02907359
What this trial is testing

Guadecitabine (SGI-110) vs Treatment Choice in Adults With MDS or CMML Previously Treated With HMAs

Who this might be right for
Myelodysplastic SyndromesLeukemia, Myelomonocytic, Chronic
Astex Pharmaceuticals, Inc. 417
Early research (Phase 1)Study completedNCT00098826
What this trial is testing

SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes

Who this might be right for
Acute Undifferentiated LeukemiaAdult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)+24 more
National Cancer Institute (NCI) 40
Early research (Phase 1)Study completedNCT00006042
What this trial is testing

Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT01216085
What this trial is testing

An Exploratory Study of High-dose Glivec in Patients With CML-CP Using Molecular Endpoints

Who this might be right for
CMLImatinib
Novartis Pharmaceuticals 10
Early research (Phase 1)Study completedNCT00064285
What this trial is testing

Flavopiridol and Imatinib Mesylate in Treating Patients With Hematologic Cancer

Who this might be right for
Leukemia
Virginia Commonwealth University 22
Not applicableStudy completedNCT03647215
What this trial is testing

CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey

Who this might be right for
Chronic Phase Chronic Myelogenous LeukemiaAccelerated Phase Chronic Myelogenous LeukemiaBlastic Phase Chronic Myelogenous Leukemia+1 more
Incyte Biosciences UK 427
Not applicableStudy completedNCT00445731
What this trial is testing

A Structured Walking Program or Standard Therapy in Cancer Patients Undergoing a Donor Bone Marrow Transplant

Who this might be right for
Cancer
University of Minnesota 115
Testing effectiveness (Phase 2)WithdrawnNCT00085449
What this trial is testing

Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+2 more
Alliance for Clinical Trials in Oncology
Not applicableWithdrawnNCT02421926
What this trial is testing

Extension Study of IDEAL (Imatinib) for Chronic Myelgenous Leukemia (CML)

Who this might be right for
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Asan Medical Center
Testing effectiveness (Phase 2)Study completedNCT00003415
What this trial is testing

Amifostine Plus Topotecan in Treating Patients With Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
University of Arizona 26
Testing effectiveness (Phase 2)Study completedNCT00003887
What this trial is testing

Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Fred Hutchinson Cancer Center
Not applicableStudy completedNCT00453206
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+2 more
Wake Forest University Health Sciences 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT04493138
What this trial is testing

Azacitidine and Quizartinib for the Treatment of Myelodysplastic Syndrome or Myelodysplastic/Myeloproliferative Neoplasm With FLT3 or CBL Mutations

Who this might be right for
Chronic Myelomonocytic LeukemiaMyelodysplastic SyndromeMyeloproliferative Neoplasm+3 more
M.D. Anderson Cancer Center 30
Early research (Phase 1)Study completedNCT01075425
What this trial is testing

Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome

Who this might be right for
Acute Lymphocytic LeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome+1 more
Virginia Commonwealth University 41
Next Page